Home / Spain / Oryzon Genomics, S.A.
Oryzon Genomics, S.A.
Short position disclosed on October 5, 2026.
0.60% of the capital sold short
1 disclosing fund
128 disclosures on record
ES0167733015 ISIN code
Evolution of the disclosed total
0%1%2%3%4%
2025-13-01Apr 2026Jul 2026Oct 2026
March 21, 2025 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Voleon Capital Management LP | 0.60% | -2.51 pt | October 5, 2026 |
On the other side: the funds that hold Oryzon Genomics, S.A. Titelia
Get the moves on Oryzon Genomics, S.A. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 128 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Spain
- Solaria Energia y Medioambiente, S.A. 8.13% of the capital sold short
- Enagas, S.A. 4.21% of the capital sold short
- Tecnicas Reunidas, S.A. 3.91% of the capital sold short
- Viscofan, S.A. 3.10% of the capital sold short
- Edreams Odigeo, S.A. 3.09% of the capital sold short
- Grifols, S.A. 1.78% of the capital sold short
- Sacyr, S.A. 1.77% of the capital sold short
- Cellnex Telecom, S.A. 1.59% of the capital sold short
- Laboratorios Farmaceuticos Rovi, S.A. 1.51% of the capital sold short
- Ence Energia y Celulosa, S.A. 1.37% of the capital sold short
- Amper, S.A. 1.29% of the capital sold short
- Indra Sistemas, S.A. 1.28% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Oryzon Genomics, S.A., source CNMV, data as at October 5, 2026, https://www.quivad.com/action/oryzon-genomics-s-a?page=3